Meeting abstracts Myeloid-derived suppressor cells (MDSC) promote tumor growth by inhibiting T cell immunity and supporting malignant cell proliferation and migration. The therapeutic potential of blocking MDSC in tumors has been limited by their heterogeneity, plasticity, and resistance to various
No takes yet. Share an insight, caveat, or question.
Al-Khami et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: